Aradigm Corporation Stock Nasdaq
Equities
US0385054004
Biotechnology & Medical Research
Financials (USD)
Sales 2016 | 195K | Sales 2017 | 14.46M | Capitalization | 97.3M |
---|---|---|---|---|---|
Net income 2016 | -32M | Net income 2017 | -10M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M | Net Debt 2017 | 7.91M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |